Uncategorised

January 2025 

• I really like Rachel King. She is clearly very competent and has a confident manner.
• I think Dr Wong is polite and listens and looks into your illness and all the options. If she doesn’t know she will say so. I feel confident with Dr Wong
• Dr Smith is always brilliant and Rebecca is great

The updated JCVI guidance on booster vaccinations for pregnant women can be found by clicking on the following link 

If you're pregnant, or think you might be, you can have the COVID-19 vaccine.

It's preferable for you to have the Pfizer/BioNTech or Moderna vaccine. This is because they've been more widely used during pregnancy in other countries and have not caused any safety issues.

So far 10000 patients at Chevin medical Practice have had at least one vaccination with just over half receiving AstraZeneca. We have had no problems of concern.

Nationally we have given 20 million AstraZeneca doses and there is a possible link in 79 cases of an extremely specific and unusual brain clot. This is quite distinct to other clotting problems.

We strongly recommend patients keep up with their vaccination offers. This is an essential tool in protecting yourself, your family and your co-workers and/or those you provide care for.

Unlike some centres, all our patients are pre-screened as best we can (based on latest evidence) with the benefit of your clinical records and knowledge - to add additional safety checks.

If you are a healthy younger person aged 18 to 29

The link attached gives reassurance about the reasons for the latest advice on a slight change in policy to offer choice (when available) to those young adults when their turn comes for vaccine. Anyone in this age group with long-term conditions or additional risks should have the vaccination as offered without change from AstraZeneca and anyone already vaccinated with this should have their second when offered. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/976880/PHE_COVID-19_AZ_vaccination_guide.pdf

We cannot offer choice of vaccination to anyone outside of that age group - and for reasons beyond our control with supply and deliveries, we may not have alternatives to offer in the next few weeks for fit and well young adults under the age of 30 eligible early (due to a role as a paid carer for instance). We think we have reached out and already vaccinated that group at least once.

Chevin Medical Practice has opted in to Phase 2 (Cohorts 10-12) – which is the 18 – 49 year old and are awaiting delivery schedules and permissions to progress at scale in these cohorts.

We ask that you do not contact the surgery to query these vaccine types or your specific circumstances as we are extremely busy with running a large medical practice dealing with all the other issues of providing healthcare to over 19000 patients – if you can not find info via the link attached you can use the eConsult link below to send a query – allowing a few days for a reply please.

If you are a healthy person aged 30-39

JCVI has advised a preference for adults aged 30 to 39 without underlying health conditions to receive an alternative to the Oxford/AstraZeneca vaccine – where available and only if this does not cause substantial delays in being vaccinated.

If you already have an appointment booked in an AstraZeneca clinic at the surgery, you must read the Patien Information Leaflet and the latest advice before attending your appointment; this will be considered your consent.

At the moment we do not know when further stocks of an alternative vaccine will be received, which could delay your vaccination by a number of weeks and could potentially mean your second vaccination would not take place until after the summer months (11-12 weeks after your first).  If you would prefer to cancel your appointment we will place your name on a waiting list and will contact you again when we receive alternative supplies.

Thank you for supporting our teams in supporting you (and the wider practice population) at this important phase in our pandemic response.

1_Resources_to_support_practices_with_DSP_Submissions_and_GDPR_compliance.pdf
2_Toolkit_for_the_toolkit.pdf
3__data_flow_article_30_register.pdf
3_Information_Asset_Register_and_data_flow_article_30_register.pdf
4a_Confidentiality_and_Data_Protection_Policy_.pdf
4b_Data_and_Information_Security_Policy.pdf
4c_Data_Quality_Policy.pdf
4d_Network_Security_Policy.pdf
4e_FOI_Policy.pdf
4f_SAR_policy_patient.pdf
4g_Smartcard_Registration_Authority_Policy_statement.pdf
5a_DPIA_business_change_analysis_for_imposed_changes_FINAL.pdf
5b_DPIA_form_for_practices_FINAL.pdf
5c_Data_Protection_by_Design_and_by_Default_policy.pdf
6_Privacy_Notice_Aug2019.pdf
7_Subject_Access_request_SAR_procedure.pdf
8_GDPR_Guidance_for_GP_staff_FINAL.pdf
9_IG_Spot_check_template.pdf
10a_RetentionSchedule_CURRENT.pdf
10b_IGA_retention-schedules.pdf
11_How_we_use_your_information_GP_staff_FINAL.pdf
12a_Staff_IG_Awareness_Survey_2018_FINAL.pdf
12b_Staff_Information_Governance_Awareness_Survey_word_FINAL.pdf
13_Personal_Data_Breaches_reported_to_ICO__disclosure_log.pdf
14a_risk_breakdown_GP.pdf
14b_Example_risks.pdf
15_DSP_IR_guidance.pdf
16b_LCC_patch_schedule.pdf
GDPR_Data_protection_poster.pdf
GDPR_Employee_Privacy_Notice.pdf
GDPR_How_we_use_your_information.pdf
GDPR_Privacy_Notice_June_2019.pdf
IG_Breach_reporting_policy.pdf
IG_responsibilities_list.pdf
Information_Asset_Register.pdf
Information_Governance_Policy.pdf
Records_management_and_document_retention_policy.pdf
Smartcard_agreement.pdf
Smartcard_policy.pdf